Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 2:24 pm Purchase | 13G | CONTRAFECT CORP COM PAR $0.000 CFRX | ARMISTICE CAPITAL LLC | 1,395,093 9.99% | 1,395,093 (New Position) | View |
| 2023-02-14 12:22 pm Purchase | 13G | CONTRAFECT CORP COM CFRX | ARMISTICE CAPITAL LLC | 4,828,644 9.99% | 4,828,644 (New Position) | View |
| 2022-09-09 11:03 am Sale | 13G | CONTRAFECT CORP CFRX | FEDERATED HERMES INC. FHI | 1,685,391 4.11% | -5,611,797 (-76.90%) | View |
| 2022-07-19 5:13 pm Sale | 13G | CONTRAFECT CORP COM CFRX | BIOTECHNOLOGY VALUE FUND L P | 1,847,299 4.5% | -2,125,001 (-53.50%) | View |
| 2022-02-14 1:19 pm Purchase | 13G | CONTRAFECT CORP CFRX | FEDERATED HERMES INC. FHI | 7,297,188 18.55% | 2,000,000 (+37.76%) | View |
| 2022-02-11 5:32 pm Unchanged | 13G | CONTRAFECT CORP COM CFRX | PFIZER INC PFE | 1,785,267 4.54% | 0 (Unchanged) | View |
| 2021-04-15 4:06 pm Purchase | 13G | CONTRAFECT CORP COM CFRX | BIOTECHNOLOGY VALUE FUND L P | 3,972,300 10.1% | 1,063,387 (+36.56%) | View |
| 2021-04-09 6:02 pm Purchase | 13G | CONTRAFECT CORP COM CFRX | BlackRock Inc. BLK | 1,614,857 4.1% | 28,408 (+1.79%) | View |
| 2021-02-16 09:55 am Sale | 13G | CONTRAFECT CORP COM CFRX | CVI Investments Inc. | 1,460,607 4.9% | -786,581 (-35.00%) | View |
| 2021-02-16 06:42 am Unchanged | 13G | CONTRAFECT CORP COM CFRX | Altium Capital Management LP | 1,500,000 4.99% | 0 (Unchanged) | View |
| 2021-02-12 5:17 pm Purchase | 13G | CONTRAFECT CORP COM CFRX | PFIZER INC PFE | 1,785,267 6.4% | 1,785,267 (New Position) | View |
| 2021-02-12 12:34 pm Sale | 13G | CONTRAFECT CORP CFRX | FEDERATED HERMES INC. FHI | 5,297,188 19.05% | -25,202,812 (-82.63%) | View |
| 2021-02-02 3:13 pm Purchase | 13G | CONTRAFECT CORP COM CFRX | BlackRock Inc. BLK | 1,586,449 5.7% | 1,586,449 (New Position) | View |
| 2021-01-26 06:06 am Unchanged | 13G | CONTRAFECT CORP COM CFRX | Fosun Industrial Co. Ltd | 1,170,385 4.1% | 0 (Unchanged) | View |
| 2020-10-20 08:59 am Purchase | 13G | CONTRAFECT CORP COM CFRX | BIOTECHNOLOGY VALUE FUND L P | 2,908,913 9.99% | 2,908,913 (New Position) | View |
| 2020-06-01 5:09 pm Purchase | 13G | CONTRAFECT CORP COM CFRX | Altium Capital Management LP | 1,500,000 5.5% | 1,500,000 (New Position) | View |
| 2020-05-29 10:41 am Purchase | 13G | CONTRAFECT CORP COM CFRX | CVI Investments Inc. | 2,247,188 8.3% | 2,247,188 (New Position) | View |
| 2020-02-14 4:14 pm Sale | 13G | CONTRAFECT CORP CFRX | BAKER BROS. ADVISORS LP | 5,553,599 3.5% | -2,465,977 (-30.75%) | View |
| 2020-02-14 4:08 pm Sale | 13G | CONTRAFECT CORP CFRX | FEINBERG LARRY N | 2,502,766 1.62% | -4,217,006 (-62.76%) | View |
| 2020-02-12 4:32 pm Sale | 13G | CONTRAFECT CORP CFRX | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,880,000 3.51% | -120,000 (-4.00%) | View |